BioCentury
ARTICLE | Company News

DARPA awards Moderna up to $25M for mRNA therapeutics

October 3, 2013 12:22 AM UTC

Moderna Therapeutics Inc. (Cambridge, Mass.) said the Defense Advanced Research Projects Agency (DARPA) awarded it a grant worth up to $24.6 million to develop antibody-producing drugs for infectious diseases and biological threats. The company said it expects the grant to support research for up to five years to advance drug candidates from its mRNA therapeutics platform into preclinical and clinical testing. Moderna declined to provide financial details. ...